Skip to main content

UW Medicine administers new Alzheimer's drug for the first time

By The Seattle Times  
   December 04, 2023

The IV drug, created by Japanese drugmaker Eisai, is covered by Medicare and deemed safe and effective for patients with mild dementia and other symptoms caused by early Alzheimer's.

Full story

Tagged Under:

Get the latest on healthcare leadership in your inbox.